Impax Laboratories Inc
George Hill is an experienced finance professional currently serving as Vice President of Finance at Impax Laboratories since June 2013. Prior to this role, George held the position of Global Controller at Quaker Chemical Corporation from October 2002 to June 2013, and served as Audit Manager at PwC from September 1996 to October 2002. Academic credentials include a Master of Taxation and an MBA with a Finance Concentration, both from Villanova University, as well as a Bachelor of Arts in Accounting from Franklin & Marshall College. George's foundational education was completed at The Lawrenceville School.
This person is not in any teams
This person is not in any offices
Impax Laboratories Inc
Impax Laboratories, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. Its segments include Impax Generics and Impax Specialty Pharma. The Impax Generics segment is focused on the development, manufacture, sale and distribution of its generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their established drug names. The Impax Specialty Pharma segment is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease, post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.